Gorsline Chelsea A, Miller Ryan M, Bobbitt Laura J, Satyanarayana Gowri, Baljevic Muhamed, Staub Milner B O
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Antimicrob Steward Healthc Epidemiol. 2023 Apr 17;3(1):e76. doi: 10.1017/ash.2023.125. eCollection 2023.
To design and implement "handshake rounds" as an antibiotic stewardship intervention to reduce inpatient intravenous (IV) antibiotic use in patients with hematologic malignancies.
Quasi-experimental analysis of antibiotic use (AU) and secondary outcomes before and and after handshake rounds were implemented.
Quaternary-care, academic medical center.
Hospitalized adults with hematologic malignancies receiving IV antibiotics.
We performed a retrospective review of a preintervention cohort prior to the intervention. A multidisciplinary team developed criteria for de-escalation of antibiotics, logistics of handshake rounds, and outcome metrics. Eligible patients were discussed during scheduled handshake rounds between a hematology-oncology pharmacist and transplant-infectious diseases (TID) physician. Prospective data were collected over 30 days in the postintervention cohort. Due to small sample size, 2:1 matching was used to compare pre- to and postintervention AU. Total AU in days of therapy per 1,000 patient days (DOT/1,000 PD) was reported. Mean AU per patient was analyzed using Wilcoxon rank-sum test. A descriptive analysis of secondary outcomes of pre- and postintervention cohorts was performed.
Total AU was substantially lower after the intervention, with 517 DOT/1,000 PD compared to 865 DOT/1,000 PD before the intervention. There was no statistically significant difference in the mean AU per patient between the 2 cohorts. There was a lower rate of 30-day mortality in the postintervention cohort and rates of ICU admissions were similar.
Conducting handshake rounds is a safe and effective way to implement an antibiotic stewardship intervention among high-risk patient population such as those with hematologic malignancies.
设计并实施“握手查房”作为一种抗生素管理干预措施,以减少血液系统恶性肿瘤患者的住院静脉抗生素使用。
对实施握手查房前后的抗生素使用(AU)及次要结局进行准实验分析。
四级医疗学术医学中心。
接受静脉抗生素治疗的住院血液系统恶性肿瘤成人患者。
我们对干预前的一个队列进行了回顾性研究。一个多学科团队制定了抗生素降阶梯标准、握手查房的流程以及结局指标。在血液肿瘤药师和移植感染病(TID)医师安排的握手查房期间,对符合条件的患者进行讨论。在干预后队列中前瞻性收集30天的数据。由于样本量小,采用2:1匹配来比较干预前后的AU。报告每1000患者日治疗天数中的总AU(DOT/1000 PD)。使用Wilcoxon秩和检验分析每位患者的平均AU。对干预前后队列的次要结局进行描述性分析。
干预后总AU显著降低,干预后为517 DOT/1000 PD,而干预前为865 DOT/1000 PD。两个队列中每位患者的平均AU无统计学显著差异。干预后队列的30天死亡率较低,重症监护病房入院率相似。
开展握手查房是在血液系统恶性肿瘤等高危患者群体中实施抗生素管理干预的一种安全有效的方法。